Filtered Search Results
| Content And Storage | -20°Cor to +80°C if preferred |
|---|---|
| Purity or Quality Grade | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | KGF |
| Molecular Weight (g/mol) | 18.9 kDa |
| Gene Symbol | FGF7 |
| Activity | Determined by the proliferation of 4 MBr5 cells. |
| Endotoxin Concentration | <0.1 EU/ μg |
| Sequence | CNDMTPEQMA TNVNCSSPER HTRSYDYMEG GDIRVRRLFC RTQWYLRIDK RGKVKGTQEM KNNYNIMEIR TVAVGIVAIK GVESEFYLAM NKEGKLYAKK ECNEDCNFKE LILENHYNTY ASAKWTHNGG EMFVALNQKG IPVRGKKTKK EQKTAHFLPM AIT |
| Expression System | E. coli |
| For Use With (Application) | Functional Assay |
| Name | PeproGMP™ Human FGF-7 (KGF) |
| Accession Number | P21781 |
| Regulatory Status | RUO |
| Purification Method | HPLC, SDS-PAGE |
| Gene Alias | Fgf7; FGF-7; Fibroblast growth factor 7; HBGF-7; Heparin-binding growth factor 7; keratinocyte growth factor; Kgf |
| Format | Lyophilized |
| Product Type | Protein |
| Biological Activity | Determined by the proliferation of 4 MBr5 cells. |
| Gene ID (Entrez) | 2252 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°Cor to +80°C if preferred |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IL-21 |
| Molecular Weight (g/mol) | 15.4 kDa |
| Activity | Determined by the proliferation of ANBL-6 cells. |
| Endotoxin Concentration | <0.1 EU/ μg |
| Sequence | MQDRHMIRMR QLIDIVDQLK NYVNDLVPEF LPAPEDVETN CEWSAFSCFQ KAQLKSANTG NNERIINVSI KKLKRKPPST NAGRRQKHRL TCPSCDSYEK KPPKEFLERF KSLLQKMIHQ HLSSRTHGSE DS |
| Expression System | E. coli |
| For Use With (Application) | Functional Assay |
| Name | PeproGMP™ Human IL-21 |
| Accession Number | Q9HBE4 |
| Regulatory Status | RUO |
| Gene Alias | CVID11; C x 2; il 21; IL21; IL-21; ILN; Interleukin; interleukin 21; Interleukin21; interleukin-21; interleukin-21 isoform; porcine interleukin-21; Za11 |
| Format | Lyophilized |
| Biological Activity | Determined by the proliferation of ANBL-6 cells. |
| Gene ID (Entrez) | 59067 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°Cor to +80°C if preferred |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | LIF |
| Molecular Weight (g/mol) | 19.7 kDa |
| Activity | Determined by the proliferation of TF-1 cells. |
| Endotoxin Concentration | <0.1 EU/ μg |
| Sequence | SPLPITPVNA TCAIRHPCHN NLMNQIRSQL AQLNGSANAL FILYYTAQGE PFPNNLDKLC GPNVTDFPPF HANGTEKAKL VELYRIVVYL GTSLGNITRD QKILNPSALS LHSKLNATAD ILRGLLSNVL CRLCSKYHVG HVDVTYGPDT SGKDVFQKKK LGCQLLGKYK QIIAVLAQAF |
| Expression System | E. coli |
| For Use With (Application) | Functional Assay |
| Name | PeproGMP™ Human LIF |
| Accession Number | P15018 |
| Regulatory Status | RUO |
| Gene Alias | CDF; cholinergic differentiation factor; cholinergic neuronal differentiation factor; d factor; DIA; differentiation inhibitory activity; differentiation-inducing factor; differentiation-stimulating factor; Emfilermin; hepatocyte-stimulating factor III; HILDA; human interleukin in DA cells; leukemia inhibitory factor; leukemia inhibitory factor (cholinergic differentiation factor); LIF; Melanoma-derived LPL inhibitor; MLPLI; myeloid leukaemia inhibitory factor |
| Format | Lyophilized |
| Biological Activity | Determined by the proliferation of TF-1 cells. |
| Gene ID (Entrez) | 3976 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°Cor to +80°C if preferred |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | PDGF-AA |
| Molecular Weight (g/mol) | 28.5 kDa |
| Activity | Determined by the proliferation of mouse Balb/c 3T3 cells. |
| Endotoxin Concentration | <0.1 EU/ μg |
| Sequence | SIEEAVPAVC KTRTVIYEIP RSQVDPTSAN FLIWPPCVEV KRCTGCCNTS SVKCQPSRVH HRSVKVAKVE YVRKKPKLKE VQVRLEEHLE CACATTSLNP DYREEDTGRP RESGKKRKRK RLKPT |
| Expression System | E. coli |
| For Use With (Application) | Functional Assay |
| Name | PeproGMP™ Human PDGF-AA |
| Accession Number | P04085 |
| Regulatory Status | RUO |
| Gene Alias | H-PDGF-AA; PDGF A-chain; PDGF subunit A; PDGF1; PDGF-1; Pdgfa; PDGF-A; PDGFACP; platelet derived growth factor subunit A; platelet derived growth factor, alpha; Platelet-derived growth factor A chain; platelet-derived growth factor A-chain; platelet-derived growth factor alpha chain; platelet-derived growth factor alpha polypeptide; Platelet-derived growth factor subunit A; Rpa1 |
| Format | Lyophilized |
| Biological Activity | Determined by the proliferation of mouse Balb/c 3T3 cells. |
| Gene ID (Entrez) | 5154 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°Cor to +80°C if preferred |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | VEGF-165 |
| Molecular Weight (g/mol) | 38.2 kDa |
| Activity | Determined by the proliferation of HUVECs. |
| Endotoxin Concentration | <0.1 EU/ μg |
| Sequence | APMAEGGGQN HHEVVKFMDV YQRSYCHPIE TLVDIFQEYP DEIEYIFKPS CVPLMRCGGC CNDEGLECVP TEESNITMQI MRIKPHQGQH IGEMSFLQHN KCECRPKKDR ARQENPCGPC SERRKHLFVQ DPQTCKCSCK NTDSRCKARQ LELNERTCRC DKPRR |
| Expression System | E. coli |
| For Use With (Application) | Functional Assay |
| Name | PeproGMP™ Human VEGF-165 |
| Accession Number | P15692 |
| Regulatory Status | RUO |
| Gene Alias | H-VEGF-165; MVCD1; M-VEGF-165; vascular endothelial growth factor 165 b; vascular endothelial growth factor A; vascular endothelial growth factor A121; vascular endothelial growth factor A165; vascular permeability factor; VEGF; VEGF164; VEGF165; Vegfa; VEGF-A; VPF |
| Format | Lyophilized |
| Biological Activity | Determined by the proliferation of HUVECs. |
| Gene ID (Entrez) | 7422 |
| Formulation | protein with no preservative |
| Recombinant | Recombinant |
Gibco™ Fetal Bovine Serum, Tet system approved, USDA-approved regions
Tet system-approved FBS is formulated for cell culture applications using tetracycline- and tetracycline derivative-regulated gene expression systems.
| Shipping Condition | Frozen |
|---|---|
| Content And Storage | Store at <-10°C. |
| Purity or Quality Grade | Value |
| Green Features | Sustainable packaging |
| Endotoxin Concentration | <50 EU/mL (levels routinely <10 EU/mL) |
| Sterility | Sterile |
| Hemoglobin Concentration | <25 mg/dL |
| Cell Type | Use for a broad range of cell types, especially sensitive cell lines |
| Sterilization Method | Triple-filtered, 0.1 μm |
| Product Type | Fetal Bovine Serum |
| Classification | Value |
| Specialty Type | Tet-System Approved |
| Certifications/Compliance | ISO 13485 Certified |
| Species | Cattle/Bovine |
| Country of Origin | Mexico |
| Age | Fetal |
Gibco™ CTS™ DPBS, calcium, magnesium, bag format
Gibco Cell Therapy Systems (CTS) DPBS is the classical Dulbecco's phosphate buffered saline, which is a balanced salt solution used for a variety of cell culture applications.
Gibco™ Human Plasma-Like Medium (HPLM)
Human Plasma-like Medium (HPLM) is designed to resemble the natural cellular environment found in the body, mimicking the metabolic profile of human plasma.
| With Additives | Glutamine,Phenol Red |
|---|---|
| Product Type | Human Plasma-Like Medium |
| Form | Liquid |
| Without Additives | No HEPES |
| Culture Type | Mammalian Cell Culture |
| Shelf Life | 12 Months |
| For Use With (Application) | Mammalian Cell Culture |
| Sterility | Sterile-filtered |
| Serum Level | Standard Serum Supplementation |
| Cell Type | Mammalian Cells |
Gibco™ Fetal Bovine Serum, Tet system approved, US origin
Tet system-approved FBS is formulated for cell culture applications using tetracycline- and tetracycline derivative-regulated gene expression systems.
| Shipping Condition | Frozen/Dry Ice |
|---|---|
| Content And Storage | Store at <-10°C. |
| Purity or Quality Grade | Premium |
| Tested For | Meets USP/EP guidelines with up to 91 harmonized quality specification tests |
| Green Features | Sustainable packaging |
| Endotoxin Concentration | <5 EU/mL |
| Sterility | Sterile |
| Hemoglobin Concentration | <15 mg/dL |
| Cell Type | Use for a broad range of cell types, especially sensitive cell lines |
| Sterilization Method | Triple-filtered, 0.1 μm |
| Product Type | Fetal Bovine Serum |
| Classification | Premium |
| Specialty Type | Tet-System Approved |
| Species | Cattle/Bovine |
| Country of Origin | United States |
| Age | Fetal |
Gibco™ CTS™ TrypLE™ Select Enzyme
Greener Choice
Offers one or more environmental benefits itemized in the U.S. FTC Green Guides.
Learn More
Offers one or more environmental benefits itemized in the U.S. FTC Green Guides.
Learn More
Gibco CTS TrypLE Select is a recombinant enzyme capable of dissociating a wide range of adherent mammalian cells.
Gibco™ StemScale™ PSC Suspension Medium
Gibco StemScale PSC Suspension Medium supports the growth of pluripotent stem cells (PSCs) in suspension through the self-assembly of spheroids. The unique formulation of StemScale medium provides superior expansion while maintaining high viability and consistent spheroid formation across multiple PSC lines.
Gibco™ CTS™ B-27™ Supplement XenoFree, minus insulin (50X)
CTS B-27 Supplement XenoFree, minus insulin, is based on the classic serum-free B-27 supplement and designed to help meet regulatory requirements for cell therapy manufacturing.
Gibco™ AAV-MAX Lysis Buffer
AAV-MAX Lysis Buffer is a ready-to-use cell lysis reagent for the extraction of adeno-associated virus (AAV) particles from producer HEK293 cells. Cell lysis is detergent-based, eliminating the need for mechanical cell disruption.
Gibco™ Viral-Plex™ Complexation Buffer
A chemically defined, protein-free, phenol red-free buffer for complexing plasmid DNA with transfection reagent for standard transfection applications.
